96 related articles for article (PubMed ID: 669876)
1. The pharmacokinetics of digoxin in patients with manifest hyperthyroidism and after normalization of thyroid function.
Bonelli J; Haydl H; Hruby K; Kaik G
Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):302-6. PubMed ID: 669876
[TBL] [Abstract][Full Text] [Related]
2. [Serum levels and kinetics of digoxin in patients with hyperthyroidism (author's transl)].
Gaita F; Bocchiardo M; Brossa C; Molinatti GM; Rosettani E; Brusca A
G Ital Cardiol; 1980; 10(7):836-42. PubMed ID: 7461331
[TBL] [Abstract][Full Text] [Related]
3. The impact of thyroid disease on the regulation, expression, and function of ABCB1 (MDR1/P glycoprotein) and consequences for the disposition of digoxin.
Burk O; Brenner SS; Hofmann U; Tegude H; Igel S; Schwab M; Eichelbaum M; Alscher MD
Clin Pharmacol Ther; 2010 Nov; 88(5):685-94. PubMed ID: 20844484
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of digoxin in sheep: limitations of the use of biological half-life for interspecies extrapolation.
Dix LP; Bai SA; Rogers RA; Anderson DL; Riviere JE
Am J Vet Res; 1985 Feb; 46(2):470-2. PubMed ID: 3994115
[TBL] [Abstract][Full Text] [Related]
5. Digoxin pharmacokinetics in premature infants.
Hastreiter AR; Simonton RL; van der Horst RL; Benawra R; Mangurten H; Lam G; Chiou WL
Pediatr Pharmacol (New York); 1982; 2(1):23-31. PubMed ID: 7110753
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic studies of nifedipine and digoxin co-administration.
Koren G; Zylber-Katz E; Granit L; Levy M
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):39-42. PubMed ID: 3957488
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the pharmacokinetics of digoxin in patients with hyperthyroidism].
Gilfrich HJ
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1726-8. PubMed ID: 1030093
[No Abstract] [Full Text] [Related]
8. Pharmacokinetics of digoxin in low-birth-weight infants.
Collins-Nakai RL; Schiff D; Ng PK
Dev Pharmacol Ther; 1982; 5(1-2):86-97. PubMed ID: 7151640
[TBL] [Abstract][Full Text] [Related]
9. [Effect of age on the pharmacokinetic parameters of digoxin].
Korkushko OV; Orlov PA; Bezverkhaia IS; Belyĭ AA
Farmakol Toksikol; 1984; 47(3):101-4. PubMed ID: 6734802
[TBL] [Abstract][Full Text] [Related]
10. Estimation of pharmacokinetic parameters of digoxin from serum, saliva and urine.
Allonen H; Iisalo E; Kangas L; Lammintausta R; Salonen M
Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):420-3. PubMed ID: 700915
[TBL] [Abstract][Full Text] [Related]
11. Digoxin disposition kinetics in dogs before and during azotemia.
Gierke KD; Perrier D; Mayersohn M; Marcus FI
J Pharmacol Exp Ther; 1978 May; 205(2):459-64. PubMed ID: 641840
[TBL] [Abstract][Full Text] [Related]
12. Multiple-dose kinetics of digoxin in neonates.
Collins-Nakai RL; Schiff D; Ng PK
Pediatr Pharmacol (New York); 1985; 5(2):117-22. PubMed ID: 4047750
[TBL] [Abstract][Full Text] [Related]
13. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
[TBL] [Abstract][Full Text] [Related]
14. Digoxin pharmacokinetics and dosage requirements in pediatric patients.
Bendayan R; McKenzie MW
Clin Pharm; 1983; 2(3):224-35. PubMed ID: 6349908
[TBL] [Abstract][Full Text] [Related]
15. Tritiated digoxin: studies in renal disease in human subjects.
Doherty JE; Bissett JK; Kane JJ; de Soyza N; Murphy ML; Flanigan WJ; Dalrymple GV
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):89-95. PubMed ID: 1100542
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of bioavailability and enteral absorption of digoxin, beta-acetyldigoxin and beta-methhyldigoxin. Measurement of cumulative renal excretion after a single application (author's transl)].
Greeff K; Hafner D; Strobach H; Wirth KE
Arzneimittelforschung; 1977; 27(12):2358-64. PubMed ID: 580051
[No Abstract] [Full Text] [Related]
17. Extrarenal clearance, distribution volume, and elimination rate of digoxin and metildigoxin in anuric patients.
Twittenhoff WD; Strauch M; Kütemeyer M; Koch K; Schaumann W
Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):405-8. PubMed ID: 7298247
[TBL] [Abstract][Full Text] [Related]
18. Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?
Rameis H
Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):145-53. PubMed ID: 3997300
[TBL] [Abstract][Full Text] [Related]
19. [Serum level and urinary excretion of 14C-thiamozol in patients with hyperthyroidism (author's transl)].
Balzer J; Lahrtz HG; van Zwieten PA
Dtsch Med Wochenschr; 1975 Mar; 100(11):548-52. PubMed ID: 1116437
[TBL] [Abstract][Full Text] [Related]
20. Plasma and urinary digoxin in thyroid dysfunction.
Shenfield GM; Thompson J; Horn DB
Eur J Clin Pharmacol; 1977 Dec; 12(6):437-43. PubMed ID: 598418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
